» Articles » PMID: 19136434

Host-microbe Interactions and Defense Mechanisms in the Development of Amoebic Liver Abscesses

Overview
Specialty Microbiology
Date 2009 Jan 13
PMID 19136434
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Amoebiasis by Entamoeba histolytica is a major public health problem in developing countries and leads to several thousand deaths per year. The parasite invades the intestine (provoking diarrhea and dysentery) and the liver, where it forms abscesses (amoebic liver abscesses [ALAs]). The liver is the organ responsible for filtering blood coming from the intestinal tract, a task that implies a particular structure and immune features. Amoebae use the portal route and break through the sinusoidal endothelial barrier to reach the hepatic parenchyma. When faced with systemic and cell-mediated defenses, trophozoites adapt to their new environment and modulate host responses, leading to parasite survival and the formation of inflammatory foci. Cytopathogenic effects and the onset of inflammation may be caused by diffusible products originating from parasites and/or immune cells either by their secretion or by their release after cell death. Liver infection thus results from the interplay between E. histolytica and hepatic cells. Despite its importance in terms of public health burden, the lack of integrated data on ALA genesis means that we have only an incomplete description of the initiation and development of hepatic amoebiasis. Here, we review the main steps of ALA development as well as the responses triggered in both the host and the parasite. Transcriptome studies highlighted parasite factors involved in adherence to human cells, cytopathogenic effects, and adaptative and stress responses. An understanding of their role in ALA development will help to unravel the host-pathogen interactions and their evolution throughout the infection.

Citing Articles

Diversity and Plasticity of Virulent Characteristics of .

Yanagawa Y, Singh U Trop Med Infect Dis. 2023; 8(5).

PMID: 37235303 PMC: 10222173. DOI: 10.3390/tropicalmed8050255.


Pathologic characteristics of infectious diseases in macaque monkeys used in biomedical and toxicologic studies.

Ohta E J Toxicol Pathol. 2023; 36(2):95-122.

PMID: 37101957 PMC: 10123295. DOI: 10.1293/tox.2022-0089.


Pathogenicity and virulence of , the agent of amoebiasis.

Guillen N Virulence. 2022; 14(1):2158656.

PMID: 36519347 DOI: 10.1080/21505594.2022.2158656.


ArfX2 GTPase Regulates Trafficking From the Trans-Golgi to Lysosomes and Is Necessary for Liver Abscess Formation in the Protozoan Parasite .

Saito-Nakano Y, Makiuchi T, Tochikura M, Gilchrist C, Petri Jr W, Nozaki T Front Cell Infect Microbiol. 2022; 11:794152.

PMID: 34976870 PMC: 8719317. DOI: 10.3389/fcimb.2021.794152.


Entamoeba histolytica: Five facts about modeling a complex human disease in rodents.

Mendoza Cavazos C, Knoll L PLoS Pathog. 2020; 16(11):e1008950.

PMID: 33180884 PMC: 7660559. DOI: 10.1371/journal.ppat.1008950.


References
1.
Kammanadiminti S, Mann B, Dutil L, Chadee K . Regulation of Toll-like receptor-2 expression by the Gal-lectin of Entamoeba histolytica. FASEB J. 2003; 18(1):155-7. DOI: 10.1096/fj.03-0578fje. View

2.
Adams E, MACLEOD I . Invasive amebiasis. II. Amebic liver abscess and its complications. Medicine (Baltimore). 1977; 56(4):325-34. DOI: 10.1097/00005792-197707000-00004. View

3.
Elnekave K, Siman-Tov R, Ankri S . Consumption of L-arginine mediated by Entamoeba histolytica L-arginase (EhArg) inhibits amoebicidal activity and nitric oxide production by activated macrophages. Parasite Immunol. 2004; 25(11-12):597-608. DOI: 10.1111/j.0141-9838.2004.00669.x. View

4.
Arellano J, Perez-Rodriguez M, Velazquez J, Granados J, Justiniani N, Santos J . Increased frequency of HLA-DR3 and complotype SCO1 in Mexican mestizo children with amoebic abscess of the liver. Parasite Immunol. 1996; 18(10):491-8. DOI: 10.1046/j.1365-3024.1996.d01-16.x. View

5.
Ivory C, Chadee K . Activation of dendritic cells by the Gal-lectin of Entamoeba histolytica drives Th1 responses in vitro and in vivo. Eur J Immunol. 2007; 37(2):385-94. DOI: 10.1002/eji.200636476. View